Home PageNews PageShoulder Innovations Shoulder Innovations Announces Closing of a $40 Million Convertible Notes Financing Shoulder Innovations, a medical technology company exclusively focused on transforming the shoulder surgical care market,…Arboretum_JDJuly 21, 2025
Home PageNews PageViaLase ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth ViaLase, Inc., a medical technology company pioneering noninvasive femtosecond laser treatments for glaucoma, today announced…Arboretum_JDJuly 9, 2025
Home PageNews PageVirtual Incision Virtual Incision Appoints Jim Alecxih as Chief Executive Officer Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through…Arboretum_JDJune 18, 2025
Allay TherapeuticsHome PageNews Page Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…Arboretum_JDJune 5, 2025
ArboretumHome PageNews Page Arboretum Ventures Welcomes Jeff Terrell as Investment Partner Arboretum Ventures, a leading healthcare venture capital firm based in Ann Arbor, Michigan, is excited…Arboretum_JDApril 1, 2025
AtaCor MedicalHome PageNews Page AtaCor Medical Enrolls First Patients in its ASCEND EV Clinical Study AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, recently…Arboretum_JDMarch 25, 2025
Home PageNews PageShoulder Innovations Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing Shoulder Innovations, a leader in shoulder replacement technology, today announced the closing of a $40…Arboretum_JDMarch 11, 2025
Francis MedicalHome PageNews Page Francis Medical Announces Completion of Enrollment in the VAPOR 2 Pivotal Study for Vanquish Prostate Cancer Treatment Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor…Arboretum_JDFebruary 25, 2025
Allay TherapeuticsHome PageNews Page Allay Therapeutics Doses First Patients in Phase 2b Trial of ATX101 for Post-Knee Replacement Pain Management Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…Arboretum_JDFebruary 18, 2025
Home PageNews PageReprieve Cardiovascular Reprieve Cardiovascular Builds Clinical Momentum with Positive Results from FASTR Pilot Trial Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) treatment,…Arboretum_JDFebruary 13, 2025